2025 Annual Public Meeting of the Board of Directors

July 17, 2025
9-10:30am (eastern)

Each year, the Reagan-Udall Foundation for the FDA's Board of Directors conducts an annual public meeting to highlight our activities in support of the U.S. Food and Drug Administration. The meeting provides an opportunity for engagement among the Foundation's Board of Directors, FDA, and external stakeholders.

Join us on July 17 for a discussion about Agency priorities with senior FDA leaders:

Makary, Graham, Zeta

This is a hybrid event. In-person registration is currently full. Please register to attend virtually and email admin@reaganudall.org to be added to the in-person waitlist.

Register to Attend Virtually

Agenda

9am

Welcome & Call to Order

  • Richard L. Schilsky, MD, FACP, FSCT, FASCO
    Foundation Board Chair, Reagan-Udall Foundation for the FDA

FDA Leadership Discussion

  • Martin Makary, MD, MPH
    Commissioner of Food and Drugs, FDA
     
  • Grace Graham
    Deputy Commissioner for Policy, Legislation, and International Affairs, FDA
     
  • Lowell Zeta, JD
    Deputy Commissioner for Strategic Initiatives and Special Counsel for FDA

Susan C. Winckler, RPh, Esq. (moderator)

Foundation Highlights

  • Susan C. Winckler, RPh, Esq. and Richard L. Schilsky, MD, FACP, FSCT, FASCO

Panel Discussion with Foundation Board Members

  • Edward John Allera, JD
     
  • Debra L. Ness, MS, Board Treasurer
     
  • Andrew C. von Eschenbach, MD
     
  • Pietro Antonio Tataranni, MD
     
  • Susan C. Winckler, RPh, Esq.

Richard L. Schilsky, MD, FACP, FSCT, FASCO (moderator)

10:30am

Closing Remarks & Adjourn